The following is a marketing release from a developer of a new medication that they hope will eventually prove successful in treating schizophrenia. It is, however, still very early in the testing - and is only entering Phase 1 of...
Patient advocacy groups are applauding the 110th Congress for passing "The Paul Wellstone Mental Health and Addiction Equity Act" (H.R.1424). Introduced by Congressmen Patrick J. Kennedy (D-RI) and Jim Ramstad (R-MN), the bill will secure greater access to mental health...
There is good news for people fighting weight gain due to antipsychotic medications. In the past year studies have come out that indicate that the common medication side effects of increased weight gain can be minimized or eliminated by good...
Pfizer announced today that Canadians with schizophrenia now have a new treatment option. Health Canada has approved ZELDOX (ziprasidone hydrochloride), marketed under the brand name "Geodon" in the US for a number of years. The medication is now available in...
A new study shows that diabetes medication (Metformin) and lifestyle changes can help treat weight gain induced by antipsychotic medications. Last year we reported on a study (in fact a group of studies) that suggested that the common weight gain...
Several new studies which were presented last week at the yearly meeting of the American College of Neuropsychopharmacology (ANCP) demonstrated that a genetic link exists between cancer and schizophrenia. Specifically, the studies found that people who suffer from schizophrenia are...
A new study, which appears in this month's issue of the British Journal of Psychiatry, has found a connection between slow growth in early life and the later development of schizophrenia-spectrum disorder, in women. They study involved comparisons of measurements...
As compared to other parts of the body, we currently know little about the brain. Methods used to diagnose mental disorders are not as effective as are methods utilized to diagnose other types of health disorders such as diabetes or...
Severely mentally ill are at a high risk for cardiovascular disease, says a new research study. A psychiatrist at Washington University School of Medicine in St. Louis writes in The Journal of the American Medical Association (JAMA) that although mortality...
Eli Lilly, the maker of Zyprexa, said that new label changes were made as part of ongoing talks with the Food and Drug Administration (FDA). The company said that the new labels include warnings on weight gain and higher levels...
Medscape.com features a short article on some interesting research results regarding schizophrenia and diabetes. Diabetes and schizophrenia are often considered disorders that show up together. Although research doesn't know exactly why so many people with schizophrenia are at risk for...
According to 'Crying Shame', a new report published by the Priory Group, mental illness and perceptions of sufferers are still shrouded in stigma, fear and ignorance. The full 30 page report is available for download here (pdf file). In The...
People suffering from schizophrenia are at an increased risk for diabetes. Much of this risk has been attributed to medications, lifestyle, weight gain, and lack of holistic treatment. Because of this increased risk, and the fact that diabetes already impacts...
Exercise has often been a recommendation of psychotherapists as part of the treatment for depression and other mental illnesses. Exercise has been shown to be as effective as many drug treatments for depression. With exercise, not only is the person...
Recent and very preliminary research out of the UK suggests that some cases of schizophrenia may be helped by a medication that will enable brain cells to more effectively use glucose (sugar). Some very early studies being conducted at University...
On Medscape Psychiatry, Dr. C. Lindsay DeVane (PharmD), incorporating the latest research, gives a nice summary and discussion about Type 2 diabetes, schizophrenia, and the use of atypical antipsychotics. With a reminder that although there may be an increased incidence...
The good news is that most patients on atypical antipsychotics are being monitored for potential metabolic adverse side effects. The bad news is that approximately 30% still are not. According to a group presenting at the American Psychiatric Association 2007...
Antipsychotic drugs do most of their work in the brain, but they also leave behind in the bloodstream a trail of hundreds of chemicals that may be used in the future to direct better treatment for schizophrenia and other psychiatric...
New, but very preliminary, research suggests that we may be able to treat early schizophrenia symptoms (and prevent the development of full-blown schizophrenia) with antidepressant medications. This is exciting news - but of course its too early to tell how...
The National Alliance on Mental Illness (NAMI) is making its "Hearts and Minds" Educational program available for the first time, free of charge, through a video and workbook at http://www.nami.org/heartsandminds. "Too often, the medical profession and society focus on mental...
If you use an RSS reader, you can subscribe to a feed of all future entries matching 'diabetes'. [What is this?]